Showing results (131-140 of 315) with videos related to
Sort By:
Pageof 32
Blood|June 19, 2004
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCRMatthias Ritgen, Stephan Stilgenbauer, Nils von Neuhoff, et al.Leukemia & Lymphoma|June 2, 2020
Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effectsLina Jansen, Maximilian Merz, Monika Engelhardt, et al.Bone Marrow Transplantation|June 20, 2020
The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysisLorenz Selberg, Peter Stadtherr, Sascha Dietrich, et al.European Journal of Haematology|May 26, 2018
CD7 is expressed on a subset of normal CD34-positive myeloid precursorsKatharina Kriegsmann, Harald Löffler, Volker Eckstein, et al.Blood|December 8, 2005
Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphomaChristiane Pott, Carsten Schrader, Stefan Gesk, et al.Bone Marrow Transplantation|May 17, 2020
Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMTAnna Sureda, Sonja Genadieva Stavrik, Ariane Boumendil, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2018
The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working PartyCharalampia Kyriakou, Ariane Boumendil, Herve Finel, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2013
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow TransplantationHaefaa Alchalby, Tatjana Zabelina, Thomas Stübig, et al.Blood Advances|July 21, 2023
EASIX-1year and late mortality after allogeneic stem cell transplantationLambros Kordelas, Tobias Terzer, Ted Gooley, et al.Blood Advances|June 13, 2022
Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST studyNico Gagelmann, Gerald Georg Wulf, Johannes Duell, et al.Pageof 32